SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-01-005932
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHED 13G/A a2038567zsc13ga.txt SC 13G/A 23019
  Complete submission text file 0000912057-01-005932.txt   25141
Mailing Address
Business Address 215 COLLEGE RD PARAMUS NJ 07652 2012611331
SYNAPTIC PHARMACEUTICAL CORP (Subject) CIK: 0000884939 (see all company filings)

IRS No.: 222859704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45417 | Film No.: 1546317
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice